The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Volpe, Mark
    Senior Vice President born in July 1972
    Individual (3 offsprings)
    Officer
    2024-12-20 ~ now
    OF - director → CIF 0
  • 2
    Berkovic, Zoran
    Senior Vice President born in August 1977
    Individual (3 offsprings)
    Officer
    2024-12-20 ~ now
    OF - director → CIF 0
  • 3
    777, Old Saw Mill River Road, Tarrytown, New York, United States
    Corporate (2 offsprings)
    Person with significant control
    2024-12-20 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 16
  • 1
    Ilett, John Edward
    Director born in April 1968
    Individual
    Officer
    2016-02-20 ~ 2018-02-28
    OF - director → CIF 0
  • 2
    Cavanagh, Thomas
    Medical Device / Biotech Executive born in April 1965
    Individual
    Officer
    2014-11-27 ~ 2023-07-31
    OF - director → CIF 0
  • 3
    Chaya Moghrabi, Dina
    Venture Capitalist born in December 1971
    Individual (1 offspring)
    Officer
    2016-02-20 ~ 2023-01-31
    OF - director → CIF 0
  • 4
    Spak, Carl Johan
    Director born in June 1956
    Individual
    Officer
    2020-02-04 ~ 2020-04-08
    OF - director → CIF 0
  • 5
    Hayes, Paul Andrew
    Company Director born in October 1966
    Individual (20 offsprings)
    Officer
    2018-02-28 ~ 2020-02-04
    OF - director → CIF 0
  • 6
    Gaffney, Mark William-semrau
    Director born in March 1976
    Individual
    Officer
    2023-09-05 ~ 2024-12-20
    OF - director → CIF 0
  • 7
    Macleod, Kenneth, Dr
    Director born in March 1960
    Individual (3 offsprings)
    Officer
    2023-01-31 ~ 2024-12-20
    OF - director → CIF 0
  • 8
    Hristodorov, Dmitrij, Dr
    Director born in May 1986
    Individual
    Officer
    2021-02-23 ~ 2024-12-20
    OF - director → CIF 0
  • 9
    Pitchford, Nigel Aaron
    Company Director born in October 1969
    Individual (1 offspring)
    Officer
    2016-02-20 ~ 2018-02-28
    OF - director → CIF 0
  • 10
    Hasan, Rafiq, Dr
    Non-Executive Director born in May 1968
    Individual (4 offsprings)
    Officer
    2020-09-18 ~ 2024-12-20
    OF - director → CIF 0
  • 11
    Soni, Bobby G., Dr
    Director born in November 1971
    Individual
    Officer
    2018-02-28 ~ 2018-03-22
    OF - director → CIF 0
  • 12
    Yamamoto, Ronald
    Medical Device / Biotech Executive born in October 1956
    Individual
    Officer
    2014-11-27 ~ 2021-02-23
    OF - director → CIF 0
    Yamamoto, Ronald
    Company Director born in October 1956
    Individual
    2021-08-04 ~ 2022-01-27
    OF - director → CIF 0
  • 13
    Fellows, David
    Company Director born in August 1956
    Individual (1 offspring)
    Officer
    2016-05-26 ~ 2024-12-20
    OF - director → CIF 0
  • 14
    Takke, Christina
    Investor born in April 1970
    Individual
    Officer
    2016-07-15 ~ 2024-12-20
    OF - director → CIF 0
  • 15
    IP2IPO ACQUISITIONS LIMITED - 2006-04-28
    Walbrook Building, 25 Walbrook, London, England
    Corporate (4 parents, 100 offsprings)
    Officer
    2018-03-27 ~ 2024-12-20
    PE - director → CIF 0
  • 16
    IP2IPO GROUP PLC - 2006-04-26
    IP2IPO GROUP LIMITED - 2003-09-29
    IP2IPO LIMITED - 2001-07-31
    DE FACTO 929 LIMITED - 2001-05-22
    The Walbrook Building, 25 Walbrook, London, England
    Corporate (8 parents, 25 offsprings)
    Officer
    2018-03-22 ~ 2018-03-27
    PE - director → CIF 0
parent relation
Company in focus

OXULAR LIMITED

Previous name
PRECISION OCULAR LTD - 2016-10-10
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Equity
Called up share capital
379,428 GBP2023-10-31
496,491 GBP2022-10-31
157,134 GBP2021-11-01
Share premium
93,732,586 GBP2023-10-31
113,673,282 GBP2022-10-31
37,854,637 GBP2021-11-01
Other miscellaneous reserve
40,832 GBP2023-10-31
61,248 GBP2022-10-31
20,416 GBP2021-11-01
Retained earnings (accumulated losses)
93,693,502 GBP2023-10-31
126,519,043 GBP2022-10-31
Equity
0 GBP2023-10-31
9,048,159 GBP2022-10-31
16,696,006 GBP2021-11-01
Average Number of Employees
02022-11-01 ~ 2023-10-31
02021-11-01 ~ 2022-10-31
Cash and Cash Equivalents
6,809,549 GBP2023-10-31
9,799,580 GBP2022-10-31
Current Assets
11,805,114 GBP2023-10-31
14,622,305 GBP2022-10-31
Total assets
12,099,037 GBP2023-10-31
15,153,091 GBP2022-10-31
Net Assets/Liabilities
229,672 GBP2023-10-31
3,016,053 GBP2022-10-31
Profit/Loss
Retained earnings (accumulated losses)
-11,785,797 GBP2022-11-01 ~ 2023-10-31
-13,724,773 GBP2021-11-01 ~ 2022-10-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-11,785,797 GBP2022-11-01 ~ 2023-10-31
-13,724,773 GBP2021-11-01 ~ 2022-10-31
Comprehensive Income/Expense
-11,785,797 GBP2022-11-01 ~ 2023-10-31
-13,724,773 GBP2021-11-01 ~ 2022-10-31
Issue of Equity Instruments
Called up share capital
24,217 GBP2022-11-01 ~ 2023-10-31
860 GBP2021-11-01 ~ 2022-10-31
Issue of Equity Instruments
8,999,416 GBP2022-11-01 ~ 2023-10-31
860 GBP2021-11-01 ~ 2022-10-31
Equity - Income/Expense Recognised Directly
Called up share capital
24,217 GBP2022-11-01 ~ 2023-10-31
8,363 GBP2021-11-01 ~ 2022-10-31
Equity - Income/Expense Recognised Directly
8,999,416 GBP2022-11-01 ~ 2023-10-31
44,820 GBP2021-11-01 ~ 2022-10-31
Par Value of Share
Class 1 ordinary share
1 shares2022-11-01 ~ 2023-10-31
Class 2 ordinary share
1 shares2022-11-01 ~ 2023-10-31
Class 3 ordinary share
10 shares2022-11-01 ~ 2023-10-31
Class 4 ordinary share
0.01 shares2022-11-01 ~ 2023-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
38,132 shares2023-10-31
36,957 shares2022-10-31
29,454 shares2021-11-01
Class 2 ordinary share
139,298 shares2023-10-31
115,396 shares2022-10-31
115,396 shares2021-11-01
Class 3 ordinary share
1,228 shares2023-10-31
1,228 shares2022-10-31
Class 4 ordinary share
400 shares2023-10-31
400 shares2022-10-31
Related profiles found in government register
  • OXULAR LIMITED
    Info
    PRECISION OCULAR LTD - 2016-10-10
    Registered number 09331313
    The Charter Building, Vine Street, Uxbridge, Middlesex UB8 1JG
    Private Limited Company incorporated on 2014-11-27 (10 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-27
    CIF 0
  • OXULAR LIMITED
    S
    Registered number 09331313
    6th Floor, One London Wall, London, United Kingdom, EC2Y 5EB
    Limited By Shares in Companies House, England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • The Charter Building, Vine Street, Uxbridge, Middlesex, England
    Corporate (3 parents)
    Profit/Loss (Company account)
    -52,782 GBP2022-11-01 ~ 2023-10-31
    Person with significant control
    2020-08-07 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.